Inflammatory Markers Correlate With Troponin Levels in Hospitalized Patients With COVID-19
The researchers sought to characterize the relationship between inflammatory markers and baseline, maximum, and change in troponin levels.
General Infectious Diseases
Effects of Aspirin Therapy on Thrombotic Complications in COVID-19
Researchers conducted a review of patients who were tested for COVID-19 and received aspirin or NSAIDS to assess whether aspirin was protective from death, myocardial infarction, or VTE.
Benefits of ACEIs and ARBs Outweigh Risks in Most Patients With COVID-19
The researchers conducted a comprehensive systematic review and meta-analysis comparing mortality and severe adverse events associated with receipt vs nonreceipt of ACEIs or ARBs among patients with COVID-19.
FDA: Multiple Violations Found at Baltimore Plant Making COVID-19 Vaccines
The US FDA inspected the Emergent BioSolutions plant, a subcontractor of Johnson & Johnson, which was manufacturing the Janssen COVID-19 vaccine and found several violations.
A Closer Look at Cardiovascular Complications of Malaria
The researchers’ goals include systematically reviewing the existing evidence of cardiovascular involvement in infectious diseases, including tropical infectious diseases.
COVID-19 Emerging as a Multi-Organ Disease Requiring Multidisciplinary Care
In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”
Tocilizumab Does Not Improve Clinical Status, Mortality in Severe COVID-19 Pneumonia
Treatment with tocilizumab did not lead to improvement in clinical status and did not lower mortality at 28 days compared with placebo in hospitalized patients with severe pneumonia related to COVID-19.
Ascorbic Acid and Zinc Gluconate Do Not Improve COVID-19 Symptoms
Study authors examined the effect of high-dose zinc and/or ascorbic acid on the severity or reduction of SARS-CoV-2 duration compared with the standard of care.
Challenges of Global COVID-19 Vaccinations: Production, Affordability, Allocation, and Deployment
Study authors reviewed challenges to COVID-19 access (production, affordability, allocation, and deployment), paths to success, and policy implications.
High Efficacy of Pfizer COVID-19 Vaccine in a Nationwide Mass Vaccination Program
Study authors analyzed data from Israel’s largest health care organization to evaluate the effectiveness of Pfizer’s COVID-19 mRNA vaccine, BNT162b2, in a real world setting.
- Loading...
Loading...
Next post in News
Loading... 
Loading...